All filters
Slidesets
50% Adherence is enough with modern ARVS, right - Terrence Blaschke, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
The ‘third wave’ of TB drug development what’s on the horizon (for patients with or without HIV) - Kelly Dooley, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Efavirenz pharmacokinetics in HIV/TB coinfected persons initiating ART while receiving high dose rifapentine - Anthony Podany, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
In silico design of a microarray patch as a multipurpose prevention technology - Rajith Rajoli
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254 - Samit Joshi, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Novel antiviral and immune targets to cure HBV - Fabien Zoulim, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long acting HIV drugs for treatment: Data and potential implementation - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Long Acting HIV Drugs for Prevention: Data and Potential implementation - Laura Waters, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Clinical Case Presentation - Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Changes in drug interaction profiles for first-line HIV therapy over the 20 years of the Liverpool Drug Interaction website - Sara Gibbons
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Effect of CYP2b6 metabolizer status on levonorgestrel pharmacokinetics when combined with efavirenz-based antiretroviral therapy - Michelle Pham
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Drugs abuse and chemsex a new challenge for antiretroviral drug-drug interaction - Tess Martin
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Con Perspective - Andrew Hill, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Dual Maintenance for HIV: Pro Perspective - José Ramón Arribas, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Slidesets
Introduction of Simplification- Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
WHO / Perspective on the Simplification Strategies- Philippa Easterbrook, MD, FRCP, MPH, DTM&H
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
WHA / Community Perspective on the Need for Simplification- Michael Ninburg
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Canada’s Experience with Needle Exchange Programs- Mark Tyndall, MD, ScD, FRCPC
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Monitoring and Testing, Introductory Lecture- Manal El-Sayed, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Uganda’s Experience- Kenneth Kabagambe
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
The Uptake of an Innovative Approach to Reduce HCV Transmission among MSM: the NoMoreC Project- T. Prinsenberg
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019